Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. This appears to be a minor version label update with no impact on trial details or visible content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check38 days agoChange DetectedThe Revision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The previous government funding lapse notice has been removed, and core study content remains unchanged.SummaryDifference0.3%

- Check74 days agoChange DetectedA site-wide Notice about a lapse in government funding and updated operating status was added, and the page revision indicator changed from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check81 days agoChange DetectedThe changes are minor UI and metadata updates (Show glossary toggle, Last Update Submitted that Met QC Criteria wording, No FEAR Act data notice, and Revision: v3.4.0) and do not affect core study information or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.